References
- Anogen Inc. 2003 . “ For the quantitative determination of human prostate‐specific antigen (PSA) concentration in serum ” . Human PSA Elisa kit. Cat. No. EL10005. 96 tests (e-mail: [email protected]) Web site: www.anogen.ca
- Chen , K. C. , Peng , C. H. , Wang , H.‐E. , Peng , C. C. and Peng , R. Y. 2004 . Modeling of the pH‐and the temperature‐dependent deviations for the free to total PSA (prostate specific antigen) ratios for clinical predictability of prostate cancer and benign prostate hyperplasia . Bull. Math. Biol. , 66 : 423 – 445 .
- Chen , Z. , Prestigiacomo , A. and Stamey , T. A. 1995 . Purification and characterization of prostate‐specific antigen (PSA) complexed to α1‐antichymotrypsin: Potential reference materials for international standardization of PSA immunoassays . Clin. Chem. , 41 : 1273 – 1282 .
- Clinical Data . 2005 . “ Clinical data signs master distribution agreement for new PSA assay with Daiichi pure chemicals. Clinical Data ” . Newton, MA : Clinical Data Inc. NASDAQ: CLDA . February 14, 2005
- Elgert , K. D. 1996 . Immunology‐Understanding the Immune System New York : Willey-Liss, a John Wiley & Sons Inc. .
- Hochmeister , M. N. , Budowle , B. , Rudin , O. , Gehrig , C. , Borer , U. V. , Thali , M. and Dirnhofer , R. 1999 . Evaluation of prostate‐specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid . J. Forensic Sci. , 44 : 1057 – 1060 .
- Leinonen , J. , Lövgren , T. , Vormanen , T. and Stenman , U. H. 1993 . Double label time resolved immunofluorometric assay of prostate specific antigen and of its complex with antichymotrypsin . Clin. Chem. , 39 : 2099 – 2103 .
- Lilja , H. 1985 . A kallikrein serine protease in prostatic fluid cleaves the predominant seminal vesicle protein . J. Clin. Invest. , 76 : 1899 – 1903 .
- Lilja , H. 1997 . “ Free and total PSA background information and rationale for use ” . In Recent Advances in Prostate Cancer and BPH Edited by: Fritz , H. S. 195 – 197 . New York : Wiley International .
- Oberpenning , F. , Weining , C. , Brandt , B. , De Angelis , G. , Heinecke , A. , Hamm , M. , Stieber , P. , Hertle , L. , Schmidt , H. and Semjonow , A. 2003 . A new modification of the Chiron ACS Assay for total prostate‐specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer . CCLM , 41 : 90 – 94 .
- Peng , C.H. , Peng , C.C. , Hsieh , C.L. , Chen , K.C. , Huang , C.N. and Peng , R.Y. 2007 . Nonlinearity in in-vivo protein-protein interactions may build up much false data in clinical and molecular biological researches . Int. J. Mol. Adv. Sci. , 3 : 98 – 101 .
- Scripts News . 1995 . The significance of equimolar PSA assays—The latest PSA and troponin research . Script News Fall , 9 : 8–04 – 8–06 .
- Strobel , S. , Esgate , J. and Norton , K. 1995 . Discordance between commercial prostate specific antigen (PSA) assays. How PSA forms affect assay results? . Clin. Chem. , 41 : S225
- Tsukada , T. , Aria , T. and Yokoyama , M. 1995 . Development of a simple method for measuring of free prostate specific antigen in serum and preliminary clinical studies . Clin. Chem. , 41 : S229 – S230 .
- Wang , M. C. , Valenzuela , L. A. , Murphy , G. P. and Chu , T. M. 1979 . Purification of a human prostate‐specific antigen . Invest. Urol. , 17 : 159 – 163 .
- Wang , M. C. , Papsidero , L. D. , Kuriyama , M. , Valenzuela , L. A. , Murphy , G. P. and Chu , T. M. 1981 . Prostate antigen: a new potential marker for prostate cancer . Prostate , 2 : 89 – 96 .